<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03118024</url>
  </required_header>
  <id_info>
    <org_study_id>16-101-0293</org_study_id>
    <nct_id>NCT03118024</nct_id>
  </id_info>
  <brief_title>Perioperative Management of DIEP Flaps</brief_title>
  <official_title>Perioperative Management of Deep Inferior Epgastric Perforator (DIEP) Flap for Breast Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Regensburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Regensburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      By comparison of two different protocols with diverse fluid/ catecholamine administration
      limits (fluid restriction vs. catecholamine restriction with target systolic blood pressure &gt;
      100 mmHg) the investigators would like to reveal the impact of intraoperative blood pressure
      management on the survival rate of free deep inferior epigastric artery flaps for breast
      reconstruction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2017</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Free flap survival rate</measure>
    <time_frame>5 days postoperatively</time_frame>
    <description>Rates of (partial) flap loss in each study arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Period of hospitalization</measure>
    <time_frame>up to 14 days</time_frame>
    <description>Length of postoperative hospitalization in each study arm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mammaplasty</condition>
  <condition>Microsurgery</condition>
  <condition>Free Tissue Flaps</condition>
  <arm_group>
    <arm_group_label>Fluid restriction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Crystalloid fluid max. 2.0 ml/kg/h, no administration of colloids, noradrenaline max. 0.15 µg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Catecholamine restriction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Noradrenaline max. 0.04 µg/kg/min, fluids max. 8.0 ml/kg/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crystalloid Solutions</intervention_name>
    <description>crystalloid restrictive anesthesia protocol</description>
    <arm_group_label>Fluid restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Catecholamines</intervention_name>
    <description>catecholamine restrictive anesthesia protocol</description>
    <arm_group_label>Catecholamine restriction</arm_group_label>
    <other_name>Norephinephrine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Informed consent for study participation

          -  Every patient undergoing breast reconstruction (primary and secondary reconstruction)
             with deep inferior epigastric perforator flap at our hospital is offered to
             participate in the study

        Exclusion criteria:

          -  No informed consent for study participation

          -  Patients with a high thromboembolic risk profile

          -  During pregnancy and breastfeeding

          -  Minors

          -  Patients with a health care proxy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexandra Anker, MD</last_name>
    <phone>0049 941 782 3110</phone>
    <email>aanker@caritasstjosef.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital of Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anker Alexandra, MD</last_name>
      <phone>0049 941 782 3110</phone>
      <email>aanker@caritasstjosef.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Eley KA, Young JD, Watt-Smith SR. Epinephrine, norepinephrine, dobutamine, and dopexamine effects on free flap skin blood flow. Plast Reconstr Surg. 2012 Sep;130(3):564-70. doi: 10.1097/PRS.0b013e31825dbf73.</citation>
    <PMID>22929242</PMID>
  </reference>
  <reference>
    <citation>Motakef S, Mountziaris PM, Ismail IK, Agag RL, Patel A. Emerging paradigms in perioperative management for microsurgical free tissue transfer: review of the literature and evidence-based guidelines. Plast Reconstr Surg. 2015 Jan;135(1):290-9. doi: 10.1097/PRS.0000000000000839. Review.</citation>
    <PMID>25539313</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>April 12, 2017</last_update_submitted>
  <last_update_submitted_qc>April 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Regensburg</investigator_affiliation>
    <investigator_full_name>Dr. Alexandra Anker</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>deep inferior epigastric perforator flap</keyword>
  <keyword>fluid restriction</keyword>
  <keyword>catecholamine restriction</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

